ProteoValent Therapeutics

Principle Scientist

Denied · decided Oct 21, 2024 · H-1B

This is a Labor Condition Application (LCA) as an employer filed it with the US Department of Labor. Certified means DOL accepted it, the step before a visa petition: it is not a visa or a hire. The wage is what the employer wrote on it. Data sources

Wage offered
$120,000 to $130,000 a year
Prevailing wage
$109,866 a year, level IV
Worksite
Dallas, TX · Dallas County
Occupation
Chemists 19-2031
Full time
Yes
Positions
1
Kind
New employment
Employment
Nov 18, 2024 to Nov 17, 2027
Received
Oct 18, 2024
Employer
ProteoValent Therapeutics
Employer’s address
Dallas, TX
FEIN
87-4368231
Industry (NAICS)
541714
H-1B dependent
Yes
Willful violator
No
Case number
I-200-24292-416991

From LCA_Disclosure_Data_FY2025_Q1.xlsx, row 81,185 (FY2025), published by the US Department of Labor on its Performance Data page.